Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Sawai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sawai's Japan sales performance.

AZ divests European rights for cholesterol med Crestor to Grünenthal

AZ divests European rights for cholesterol med Crestor to Grünenthal

AZ will continue to sell the drug in countries not included in the agreement, including North America, Japan and China.

Biogen signs $3.1bn deal with Sage for potential depression therapies

Biogen signs $3.1bn deal with Sage for potential depression therapies Outside the US, Biogen will hold responsibility for development and commercialisation with respect to zuranolone, excluding Japan, Taiwan and South Korea.

BMS’ Opdivo wins EU approval for second-line oesophageal cancer

BMS’ Opdivo wins EU approval for second-line oesophageal cancer Opdivo (nivolumab) first gained approval in this setting in February, after Japan’s Ministry of Health, Labour and Welfare (MHLW) approved the checkpoint inhibitor for unresectable advanced, or recurrent oesophageal cancer

Pfizer, BioNTech to submit emergency use request for COVID-19 vaccine to FDA today

Pfizer, BioNTech to submit emergency use request for COVID-19 vaccine to FDA today Rolling submissions for BNT162b2 are already ongoing in a number of regions globally, including the UK, the EU, Australia, Canada and Japan.

Pfizer, BioNTech set to price COVID-19 vaccine ‘well below typical market rates’

Pfizer, BioNTech set to price COVID-19 vaccine ‘well below typical market rates’ Pfizer and BioNTech already have several supply deals in place for BNT162b2, including deals with the EU, the UK, the US, Canada, Japan and other countries.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

digital launch
How can virtual pharma companies de-risk new product launches?
The risks and challenges involved in taking specialty drugs, biopharmaceuticals and drug/device combinations to market...
Not waving but drowning. Reflections on data curation in the age of information overload
...
digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...

Infographics